Informa
TIDES Asia: Oligonucleotide & Peptide Therapeutics
2026年2月24-26日
日本, 東京, Grand Nikko Tokyo Daiba

会前研讨会（上午） & 主要会议第1天（下午）

会前研讨会（上午） & 主要会议第1天（下午）
Optional Pre-Conference Workshops
会前研讨会（可选）
8:00am - 9:00am60 分
Workshop #1: Regulatory and Practical CMC Considerations Around Novel RNA Chemistries
研讨会1：新型RNA化学的相关法规和现实CMC考虑因素
Registration and Coffee
报到与咖啡时光
    8:00am - 9:00am60 分
    Workshop #2: Manufacturing and Characterization of Long and/or Complex Peptides
    研讨会2：长肽和/或复杂肽的制造和表征
    Registration and Coffee
    报到与咖啡时光
      9:00am - 9:10am10 分
      Workshop #1: Regulatory and Practical CMC Considerations Around Novel RNA Chemistries
      研讨会1：新型RNA化学的相关法规和现实CMC考虑因素
      Workshop Moderator's Opening Remarks: Workshop #1
      研讨会主持人致开幕词：研讨会1
      • Thomas Rupp - Owner & Principal, Thomas Rupp Consulting
      9:00am - 9:10am10 分
      Workshop #2: Manufacturing and Characterization of Long and/or Complex Peptides
      研讨会2：长肽和/或复杂肽的制造和表征
      Workshop Moderator's Opening Remarks: Workshop #2
      研讨会主持人致开幕词：研讨会2
      • Bruce Morimoto, PhD - Independent Consultant, TIDES Advisor
      9:10am - 9:55am45 分
      Workshop #1: Regulatory and Practical CMC Considerations Around Novel RNA Chemistries
      研讨会1：新型RNA化学的相关法规和现实CMC考虑因素
      Manufacturing and Upscale Challenges of Next-generation Oligonucleotide Therapeutics
      制造和升级下一代寡核苷酸药物的课题
      • Chris Oswald - Founder, Owner, and Principal Consultant, Coswald Consulting LLC
      9:10am - 9:55am45 分
      Workshop #2: Manufacturing and Characterization of Long and/or Complex Peptides
      研讨会2：长肽和/或复杂肽的制造和表征
      Strategies for Manufacturing of Long and Complex Peptides: Technical Considerations and Case Studies
      长肽及复杂肽的制造策略：技术考量与案例研究
      • Robert Hagopian - Global Director, Biotech Partnerships, PolyPeptide Group
      • El Djouhar Rekaï, PhD - Head of Peptide Process Development & Manufacturing, PolyPeptide Group
      9:55am - 10:40am45 分
      Workshop #1: Regulatory and Practical CMC Considerations Around Novel RNA Chemistries
      研讨会1：新型RNA化学的相关法规和现实CMC考虑因素
      Process-related Impurities of Next-generation Oligonucleotide Therapeutics
      下一代寡核苷酸治疗药物的制程相关杂质
      • Thomas Rupp - Owner & Principal, Thomas Rupp Consulting
      9:55am - 10:35am40 分
      Workshop #2: Manufacturing and Characterization of Long and/or Complex Peptides
      研讨会2：长肽和/或复杂肽的制造和表征
      Analytical Journey of a Peptide Therapeutic: A Tailored Approach
      胜肽药物的分析之旅：量身订制的方法
      • Alaric Desmarchelier, PhD - Business Development Manager - Peptides, Almac Group
      10:35am - 11:10am35 分
      Workshop #2: Manufacturing and Characterization of Long and/or Complex Peptides
      研讨会2：长肽和/或复杂肽的制造和表征
      Networking Refreshment Break
      社交茶歇
        10:40am - 11:15am35 分
        Workshop #1: Regulatory and Practical CMC Considerations Around Novel RNA Chemistries
        研讨会1：新型RNA化学的相关法规和现实CMC考虑因素
        Networking Refreshment Break
        社交茶歇
          11:10am - 11:50am40 分
          Workshop #2: Manufacturing and Characterization of Long and/or Complex Peptides
          研讨会2：长肽和/或复杂肽的制造和表征
          Innovations in Preparative Purification of Synthetic Peptides
          合成胜肽制备纯化上的创新
          • Marc Jacob, PhD - Head of Strategic Development, Chromatography Products, YMC America
          11:15am - 12:00pm45 分
          Workshop #1: Regulatory and Practical CMC Considerations Around Novel RNA Chemistries
          研讨会1：新型RNA化学的相关法规和现实CMC考虑因素
          Phase- appropriate CMC Considerations for Next-generation Oligonucleotides
          下一代寡核苷酸阶段适宜CMC的考量
          • Pablo Lores Lareo, PhD - CMC Director, Sylentis
          11:50am - 12:30pm40 分
          Workshop #2: Manufacturing and Characterization of Long and/or Complex Peptides
          研讨会2：长肽和/或复杂肽的制造和表征
          Synthesis Solutions Enabling Rapid Supply of Complex Cyclic Peptides
          能够快速供应复杂环肽的合成解决方案
          • Manabu Wadamoto, PhD - Chief Scientist, Chugai Pharmaceutical Co., Ltd.
          12:00pm - 12:30pm30 分
          Workshop #1: Regulatory and Practical CMC Considerations Around Novel RNA Chemistries
          研讨会1：新型RNA化学的相关法规和现实CMC考虑因素
          Panel Discussion and Q&A with Workshop Speakers
          研讨会演讲嘉宾主持的小组讨论与问答
            12:30pm - 1:45pm75 分
            Workshop #1: Regulatory and Practical CMC Considerations Around Novel RNA Chemistries
            研讨会1：新型RNA化学的相关法规和现实CMC考虑因素
            Close of Workshop and Luncheon for Morning Workshop Attendees Only
            研讨会结束及午餐（仅限上午研讨会与会者）
              12:30pm - 1:45pm75 分
              Workshop #2: Manufacturing and Characterization of Long and/or Complex Peptides
              研讨会2：长肽和/或复杂肽的制造和表征
              Close of Workshop and Luncheon for Morning Workshop Attendees Only
              研讨会结束及午餐（仅限上午研讨会与会者）
                1:45pm - 1:50pm5 分
                Main Conference Plenary Keynote Session
                主要会议 - 全体会议（主题演讲）
                Chairperson’s Remarks: Keynote Day 1
                议长致辞：主题演讲第1天
                  1:50pm - 2:20pm30 分
                  Main Conference Plenary Keynote Session
                  主要会议 - 全体会议（主题演讲）
                  Development of New Molecular Technologies for siRNA Therapeutics
                  开发siRNA药物的新分子技术
                  • Takeshi Wada, PhD - Professor of Organic Chemistry, Tokyo University of Science
                  2:20pm - 2:50pm30 分
                  Main Conference Plenary Keynote Session
                  主要会议 - 全体会议（主题演讲）
                  Thiomorpholino Oligonucleotides (TMOs) Useful for Exon Skipping, RNase H and siRNA Applications
                  有助于外显子跳跃、RNase H 和 siRNA 应用的TMO（硫代吗啡寡核苷酸）
                  • Marvin Caruthers, PhD - Distinguished Professor, Biochemistry, University of Colorado
                  2:50pm - 3:20pm30 分
                  Main Conference Plenary Keynote Session
                  主要会议 - 全体会议（主题演讲）
                  Latest Progress and Advances in RNAi Therapeutics
                  RNAi医药上的最新进展和发展
                  • Muthiah (Mano) Manoharan, PhD - Senior Vice President of Drug Innovation and Distinguished Research Scientist, Alnylam Pharmaceuticals
                  3:20pm - 4:00pm40 分
                  Main Conference Plenary Keynote Session
                  主要会议 - 全体会议（主题演讲）
                  Networking Refreshment Break
                  社交茶歇
                    4:00pm - 4:30pm30 分
                    Main Conference Plenary Keynote Session
                    主要会议 - 全体会议（主题演讲）
                    Emerging Technologies in the Scale Up of Oligonucleotide Therapeutics
                    寡核苷酸医药放大生产上的新兴技术
                    • Scott May, PhD - VP of Chemistry, Synthetic Molecule Design & Development, Eli Lilly and Company
                    4:30pm - 5:00pm30 分
                    Main Conference Plenary Keynote Session
                    主要会议 - 全体会议（主题演讲）
                    Clinical Development of Mazdutide, the First Dual GCG/GLP-1 Receptor Agonist Approval in China, for Chronic Weight Management
                    首个在中国获准用于慢性体重管理的GCG/GLP-1受体激动剂玛仕度肽的临床开发
                    • Lei Qian, MD, PhD - Chief R&D Officer, General Biomedicine, Innoventbio
                    5:00pm - 5:30pm30 分
                    Main Conference Plenary Keynote Session
                    主要会议 - 全体会议（主题演讲）
                    The Science Behind the GLP-1 Medicines: A Historic View and Future Outlook
                    GLP-1药物的科学背景：历史视角与未来展望
                    • Lotte Bjerre Knudsen, PhD - Chief Scientific Advisor & Head of GLP-1 CoE, Novo Nordisk A/S
                    5:30pm - 5:35pm5 分
                    Main Conference Plenary Keynote Session
                    主要会议 - 全体会议（主题演讲）
                    Close of Day One
                    第1天结束

                      * 活动内容有可能不事先告知作更动及调整。

                      Next 主要会议第2天